BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1765 related articles for article (PubMed ID: 18707817)

  • 21. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery.
    Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
    Strahlenther Onkol; 2004 Sep; 180(9):590-6. PubMed ID: 15378190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single brain metastasis: radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy.
    Rades D; Hornung D; Veninga T; Schild SE; Gliemroth J
    Cancer; 2012 Jun; 118(11):2980-5. PubMed ID: 22027993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.
    Rades D; Kueter JD; Meyners T; Pluemer A; Veninga T; Gliemroth J; Schild SE
    Clin Neurol Neurosurg; 2012 May; 114(4):326-30. PubMed ID: 22152784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.
    Tsao M; Xu W; Sahgal A
    Cancer; 2012 May; 118(9):2486-93. PubMed ID: 21887683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
    Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
    Lindvall P; Bergström P; Löfroth PO; Henriksson R; Bergenheim AT
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1460-6. PubMed ID: 15817351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
    Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
    Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
    Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma Knife radiosurgery for brain metastases from primary breast cancer.
    Kased N; Binder DK; McDermott MW; Nakamura JL; Huang K; Berger MS; Wara WM; Sneed PK
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1132-40. PubMed ID: 19345514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis.
    Rades D; Kueter JD; Veninga T; Gliemroth J; Schild SE
    Eur J Cancer; 2009 Feb; 45(3):400-4. PubMed ID: 19062269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastases.
    Hodgson DC; Charpentier AM; Cigsar C; Atenafu EG; Ng A; Bahl G; Zadeh G; San Miguel J; Menard C
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):335-40. PubMed ID: 22704984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site.
    Rades D; Raabe A; Bajrovic A; Alberti W
    Strahlenther Onkol; 2004 Mar; 180(3):144-7. PubMed ID: 14991201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
    Rades D; Haatanen T; Schild SE; Dunst J
    Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of whole brain radiotherapy combined with fractionated stereotactic radiotherapy in metastatic brain tumors, and prognostic factors.
    Kim HJ; Hong S; Kim S; Kim JH; Chie EK; Kim IH; Park CI; Ha SW; Wu HG; Kim DG; Kang WS
    Radiat Med; 2003; 21(4):155-60. PubMed ID: 14514121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.